mainadimage
An Echelon Media Company
Tuesday September 28th, 2021
Health

Sri Lanka receives 90,000 more doses of Pfizer-BioNTech

The Pfizer-BionTech COVID-19 vaccine / Image credit: Flickr

ECONOMYNEXT – Sri Lanka received 90,090 more doses of the Pfizer-BioNTech COVID-19 vaccine Monday (26) through the COVAX facility, the State Ministry of Production, Supply and Regulation of Pharmaceuticals said.

A Qatar Airways flight carrying the consignment landed at the Bandaranaike International Airport in Colombo around 2.30 am, and the vials were then transported to the National Blood Centre at Narahenpita to be stored in minus 70 degrees Celsius, the ministry said.

With the new consignment, Sri Lanka has received a total of 205,920 doses of the US-manufactured vaccine.

By July 23, health authorities had administrated the first dose of Pfizer to 113,967 Sri Lankans. The Pfizer rollout was temporarily suspended on July 24 due to a shortage, but recommenced with the arrival of more doses.

As of Sunday (25), health authorities in Sri Lanka have administrated 271,402 citizens with the first dose of the Chinese Sinopharm vaccine, while 11,485 have received the second dose. So far, 5,565,424 have received at least one dose of Sinopharm, while 1,406,224 have received both doses.

The first dose of the US-made Moderna vaccine has been administered to 670,583 by July 25.

State Minister of Production, Supply and Regulation of Pharmaceuticals Prof Channa Jayasumana said a promised 1.4 million doses of the AstraZenca vaccine has yet to arrive from Japan, 600,000 of which will go to Sri Lankans still awaiting their second shot.

Jayasumana said Japanese authorities have confirmed that the consignment will be delivered within July.

Menawhile two more million doses of Sinopharm are expected to arrive in the next two days. (Colombo/Jul 26/2021)

Tags:

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *

Comments

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *